NYSE:ALL - Allstate Stock Price, Forecast & News

Allstate trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALL."

Allstate declared a quarterly dividend on Friday, November 15th. Shareholders of record on Friday, November 29th will be given a dividend of $0.50 per share on Thursday, January 2nd. This represents a $2.00 dividend on an annualized basis and a yield of 1.70%. The ex-dividend date of this dividend is Wednesday, November 27th. View Allstate's Dividend History.

Allstate Corp (NYSE:ALL) issued its earnings results on Tuesday, October, 29th. The insurance provider reported $2.84 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.52 by $0.32. The insurance provider earned $10.87 billion during the quarter, compared to analyst estimates of $9.07 billion. Allstate had a return on equity of 13.83% and a net margin of 6.57%. During the same quarter in the previous year, the company posted $1.93 earnings per share. View Allstate's Earnings History.

Allstate is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Allstate.

Allstate will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

12 brokerages have issued 1-year price targets for Allstate's stock. Their forecasts range from $94.00 to $135.00. On average, they anticipate Allstate's share price to reach $114.64 in the next year. This suggests that the stock has a possible downside of 2.6%. View Analyst Price Targets for Allstate.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allstate in the last year. There are currently 1 sell rating, 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allstate.

Headlines about ALL stock have trended negative this week, InfoTrie reports. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allstate earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned media coverage about the insurance provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Allstate.

Allstate saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,910,000 shares, an increase of 15.0% from the December 15th total of 3,400,000 shares. Based on an average trading volume of 1,560,000 shares, the days-to-cover ratio is currently 2.5 days. Currently, 1.2% of the shares of the company are sold short. View Allstate's Current Options Chain.

Some companies that are related to Allstate include Berkshire Hathaway (BRK.B), Progressive (PGR), Travelers Companies (TRV), Arch Capital Group (ACGL), Cincinnati Financial (CINF), Markel (MKL), Fidelity National Financial (FNF), W. R. Berkley (WRB), Cna Financial (CNA), Erie Indemnity (ERIE), Old Republic International (ORI), First American Financial (FAF), Hanover Insurance Group (THG), Axis Capital (AXS) and Assured Guaranty (AGO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allstate investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), CA (CA), Honeywell International (HON), Micron Technology (MU), BlackRock (BLK), Accenture (ACN), AT&T (T), Cisco Systems (CSCO) and Allergan (AGN).

Allstate's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include PGGM Investments (0.18%), Candriam Luxembourg S.C.A. (0.10%), Gateway Investment Advisers LLC (0.08%), Zurcher Kantonalbank Zurich Cantonalbank (0.08%), Nisa Investment Advisors LLC (0.05%) and United Services Automobile Association (0.05%). Company insiders that own Allstate stock include Croker Trevor, Glenn T Shapiro, Harriet K Harty, Jesse E Merten, Judith A Sprieser, Mary Jane Fortin, Steven E Shebik and Susan L Lees. View Institutional Ownership Trends for Allstate.

ALL stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., PGGM Investments, Assenagon Asset Management S.A., Gateway Investment Advisers LLC, Dalton Greiner Hartman Maher & Co., Nisa Investment Advisors LLC, OLD National Bancorp IN and F&V Capital Management LLC. Company insiders that have sold Allstate company stock in the last year include Glenn T Shapiro, Jesse E Merten, Judith A Sprieser, Mary Jane Fortin, Steven E Shebik and Susan L Lees. View Insider Buying and Selling for Allstate.

ALL stock was acquired by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., DNB Asset Management AS, Bowling Portfolio Management LLC, Zurcher Kantonalbank Zurich Cantonalbank, Janney Montgomery Scott LLC, Allworth Financial LP, State of Alaska Department of Revenue and UNIVEST FINANCIAL Corp. View Insider Buying and Selling for Allstate.

Shares of ALL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALL stock can currently be purchased for approximately $117.65.

Allstate has a market capitalization of $38.11 billion and generates $39.82 billion in revenue each year. The insurance provider earns $2.25 billion in net income (profit) each year or $8.07 on an earnings per share basis. Allstate employs 45,700 workers across the globe.View Additional Information About Allstate.

The official website for Allstate is http://www.allstate.com/.

Allstate's mailing address is 2775 SANDERS ROAD, NORTHBROOK IL, 60062. The insurance provider can be reached via phone at 847-402-5000 or via email at [email protected]